Biomea Fusion (BMEA) Shares Issued (2021 - 2026)
Biomea Fusion (BMEA) posted Shares Issued of $4.5 million for Q1 2026, down 45.0% sequentially from $8.3 million in Q4 2025, and down 21.68% YoY from $5.8 million in Q1 2025.
Biomea Fusion (BMEA) Shares Issued (2021 - 2026) Analysis & Trends
Biomea Fusion has reported Shares Issued for 6 years, with the latest figure at $4.5 million in Q1 2026.
- Quarterly Shares Issued fell 21.68% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 21.68% YoY) and the FY2025 annual result came in at $8.3 million, down 9.96% from the prior year.
- Shares Issued declined to $4.5 million in Q1 2026 per BMEA's latest filing, from $8.3 million in the prior quarter.
- Over five years, Shares Issued peaked at $9.3 million in Q2 2024 and troughed at $906934.0 in Q1 2022.
- A 5-year average of $6.1 million and a median of $6.6 million in 2025 frame the typical range for Shares Issued.
- The widest YoY moves for Shares Issued: up 1063.09% in 2022, down 95.11% in 2022.
- Over 5 years, Shares Issued stood at $5.3 million in 2022, then soared by 37.73% to $7.4 million in 2023, then increased by 24.62% to $9.2 million in 2024, then retreated by 9.96% to $8.3 million in 2025, then tumbled by 45.0% to $4.5 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $4.5 million, $8.3 million, and $9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.18 Mn |
| Jun 30, 2026 | 13.18 Mn |
| Mar 31, 2026 | 4.54 Mn |
| Mar 31, 2026 | 4.54 Mn |
| Dec 31, 2025 | 8.26 Mn |
| Dec 31, 2025 | 8.26 Mn |
| Sep 30, 2025 | 9.01 Mn |
| Sep 30, 2025 | 9.01 Mn |
| Jun 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | 6.63 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 9.17 Mn |
| Mar 31, 2024 | 9.17 Mn |